InsiderTrades

Form 4 for QURE uniQure N.V.

Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-21 · accession 0000904454-22-000398 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-07-25 2022-07-21+ QURE Kuta Alexander Edward III Executive VP, Ops S - Sale+OE $25.00 -6,238 95.2K -6% -$155.9K
DM 2022-07-25 2022-07-21+ QURE Kuta Alexander Edward III Executive VP, Ops M - OptEx $5.31 +6,238 95.8K +7% +$33.1K
DM 2022-07-25 2022-07-21+ QURE Kuta Alexander Edward III Executive VP, Ops M - OptEx $0.00 -6,238 43.4K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2022-07-22 S D 5,643 $25.00 95,196 D — —
2 Common Ordinary Shares 2022-07-22 M A 5,643 $5.31 100,839 D — —
3 Common Ordinary Shares 2022-07-21 S D 595 $25.00 95,196 D — —
4 Common Ordinary Shares 2022-07-21 M A 595 $5.31 95,791 D — — (F3) Adjusted to correct a typographical error on the Reporting Person's last Form 4, pursuant to which the number of Ordinary Shares held after the reported transaction was inadvertently under-reported by 40 shares.
5 Derivative Stock Option (Right to Buy) 2022-07-22 M D 5,643 $0.00 37,762 D $5.31 · — to 2027-01-23 5,643 Ordinary Shares (F2) The Stock Option vested 25% on January 23, 2018 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.
6 Derivative Stock Option (Right to Buy) 2022-07-21 M D 595 $0.00 43,405 D $5.31 · — to 2027-01-23 595 Ordinary Shares (F2) The Stock Option vested 25% on January 23, 2018 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.